Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01167998
First received: July 21, 2010
Last updated: August 3, 2011
Last verified: July 2010

July 21, 2010
August 3, 2011
July 2010
August 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01167998 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
Early Diagnosis of Malignant Melanoma Transformation in Pigmentary Skin Lesions

Malignant Melanoma is a deadly skin cancer that can be cured if diagnosed early. To date atypical pigmented skin lesions are diagnosed by appearance alone and many moles and lesions are excised unnecessarily and on the other hand malignant lesions are missed and diagnosed too late. In this study a protein conjugated to a florescent dye is spread on a suspicious pigmented lesion, the hypothesis is that this protein binds to malignant cells only and thus with a special camera that picks up the dye we can find pigmented lesions with early malignant transformation.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Healthy individuals above 18 years of age with pignented skin lesions indicated for excision

  • Malignant Melanoma
  • Pigmented Nevi
  • Skin Neoplasm
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
50
Not Provided
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • pigmented lesion indicated for surgical excision
  • over 18 years of age

Exclusion Criteria:

  • pregnancy
Both
18 Years and older
Yes
Contact: Sharon Merims, MD 972-2-6777745 msharon@hadassah.org.il
Israel
 
NCT01167998
orlucent-HMO-CTIL
Yes
Catherine Shachaf, Orlucent Inc
Hadassah Medical Organization
Not Provided
Not Provided
Hadassah Medical Organization
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP